©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Dec 8, 2015; 7(28): 2819-2828
Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2819
Published online Dec 8, 2015. doi: 10.4254/wjh.v7.i28.2819
Treating morbid obesity in cirrhosis: A quest of holy grail
Naveen Kumar, Narendra Singh Choudhary, Department of Transplant Hepatology, Medanta Liver Institute, Medanta the Medicity, Gurgaon 122001, Haryana, India
Author contributions: Kumar N and Choudhary NS both wrote the paper.
Conflict-of-interest statement: The authors declare no conflict of interest for this article.
Correspondence to: Dr. Narendra Singh Choudhary, Consultant, Department of Transplant Hepatology, Medanta Liver Institute, Medanta the Medicity, CH Bakhtawar Singh Road, Gurgaon 122001, Haryana, India. docnarendra@gmail.com
Telephone: +91-124-4141414 Fax: +91-124-4834111
Received: June 28, 2015
Peer-review started: July 5, 2015
First decision: July 28, 2015
Revised: October 13, 2015
Accepted: November 17, 2015
Article in press: November 25, 2015
Published online: December 8, 2015
Processing time: 158 Days and 16.4 Hours
Peer-review started: July 5, 2015
First decision: July 28, 2015
Revised: October 13, 2015
Accepted: November 17, 2015
Article in press: November 25, 2015
Published online: December 8, 2015
Processing time: 158 Days and 16.4 Hours
Core Tip
Core tip: The rising obesity problem is also associated with increased incidence of simultaneous obesity and cirrhosis. This is a particularly difficult subset of obese patients to treat as there is difficulty in implementation of lifestyle measures, limited data on safety of anti-obesity drugs and high risk of surgery. In present review, we briefly discuss various modalities of weight reduction in obese patients and their applicability in patients with cirrhosis.